The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccines

Vaccine

Volumn 16, Issue 20, 1998, Pages 1923-1928

  Fine, Paul E M ^a   Vynnycky, Emilia ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

BCG; Heterologous immunity; Vaccine

Indexed keywords

BCG VACCINE;

ARTICLE; BCG VACCINATION; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; HUMAN; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION RISK; MYCOBACTERIUM; NONBIOLOGICAL MODEL; POPULATION EXPOSURE; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANTIBODIES, BACTERIAL; ANTIBODIES, HETEROPHILE; ANTIGENS, HETEROPHILE; BCG VACCINE; ENVIRONMENTAL EXPOSURE; HUMANS; MODELS, BIOLOGICAL; MYCOBACTERIUM; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0032400612     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00124-8     Document Type: Article

References (12)

1. 1 Fine, P.E.M. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346, 1339-1345.
2. 2 Palmer, C.E. and Long, M.W. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Respir. Dis. 1966, 94, 553-568.
3. 3 Edwards, L.B., Acquaviva, F.A., Livesay, V.T., Cross, F.W. and Palmer, C.E. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am. Rev. Respir. Dis. 1969, 99, 1-132.
4. 4 Hart, P.D. Efficacy and applicability of mass BCG vaccination in tuberculosis control. Br. Med. J. 1967, 1, 587-592.
5. 5 Comstock, G.W., Livesay, V.T. and Woolpert, S.F. Evaluation of BCG vaccination among Puerto Rican children. Am. J.Public Health 1974, 64(3), 283-291.
6. 6 Tuberculosis Prevention Trial Madras Trial of BCG vaccines in South India for tuberculosis prevention . Indian J. Med. Res. 1980, 72(Suppl), 1-74.
7. 7 Medical Research Council BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early life. Bull. WHO 1972, 46, 371-385.
8. 8 Ponnighaus, J.M., Fine, P.E.M. and Sterne, J.A.C. et al. Efficacy of BCG against leprosy and tuberculosis in Northern Malawi. Lancet 1992, 339, 636-639.
9. 9 Karonga Prevention Trial Group. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 1996, 348, 17-24.
10. 10 Comstock, G.W. and Webster, R.G. Tuberculosis studies in Muscogee County, Georgia: VII - A twenty year evaluation of BCG vaccination in a school population. Am. Rev. Respir. Dis. 1969, 100, 839-845.
11. 11 Ferguson, R.G. and Simes, A.B. BCG vaccination of Indian infants in Saskatchewan. Tubercle 1949, 30, 5-11.
12. 12 Hart, P.D'A. and Sutherland, I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Final report to the Medical Research Council. Br. Med. J. 1977, 2, 293-295.